ArticleCancers2023

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.

María José Juan Fita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.